The Effects of a Smartphone-Based Acceptance and Commitment Therapy Program on the Mental Health and Quality of Life of Caregivers Working in Long-Term Care Facilities

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorSookmyung Women's University

About this trial

The aim of this study is to investigate whether a smartphone-based Acceptance and Commitment Therapy (ACT) program can improve the mental health and quality of life of care workers in long-term care facilities. The research question of this study is as follows: Among caregivers working in long-term care facilities, are there differences in mental health, quality of life, and job burnout between the experimental group that participated in a smartphone-based ACT program and the control group that participated in a document-based ACT program?

Participants in the experimental group will complete 70 daily sessions of a smartphone-based ACT program using Anzeilax-Plus, administered Monday through Friday over a 14-week period. Participants in the control group will complete 70 daily assignments from a document-based ACT program, administered Monday through Friday over the same 14-week period.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Caregivers aged 18 years or older who provide care services to older adults in long-term care facilities, own a smartphone, and have no history of depression or other mental illnesses.

Disqualifiers

Caregivers with a history of depression or other mental illnesses, or those who do not own a smartphone.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Mobile-based Acceptance and Commitment Therapy (ACT) program

    Other intervention

    Participants will complete a daily Acceptance and Commitment Therapy (ACT) session through a mobile application on their smartphones.

  • Document-based Acceptance and Commitment Therapy (ACT) Program

    Other intervention

    Participants will complete a daily Acceptance and Commitment Therapy (ACT) session using materials provided by the research team.

Treatment groups

140 Participants
are divided into 2 treatment groups
Group A: Mobile-based ACT groupExperimental treatment 1 intervention
Group B: Document-based ACT groupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Depressive symptoms

Depressive symptoms will be measured using the Patient Health Questionnaire-9, a 9-item self-report measure. Each item is rated on a 4-point scale, with total scores ranging from 9 to 36. Higher scores indicate higher levels of depressive symptoms.

Time frame
From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
2

Anxiety

Anxiety will be measured using the Generalized Anxiety Disorder-7, a 7-item self-report measure. Each item is rated on a 4-point scale, with total scores ranging from 7 to 28. Higher scores indicate higher levels of anxiety.

Time frame
From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
3

Stress

Stress will be measured using the Perceived Stress Scale-10, a 10-item self-report measure. Each item is rated on a 5-point scale, with total scores ranging from 10 to 50. Higher scores indicate higher levels of stress.

Time frame
From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)
4

Self-esteem

Self-esteem will be measured using the Rosenberg Self-Esteem Scale, a 10-item self-report measure. Each item is rated on a 5-point scale, with total scores ranging from 10 to 50. Higher scores indicate higher levels of self-esteem

Time frame
From enrollment to Week 7 (mid-intervention) and Week 14 (end of the intervention)

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: